Difficulty: Medium
Average Score: 76%
Simulated
A nurse working in an urgent care clinic is collecting data from a client who takes montelukast. Which of the following is an expected therapeutic effect of this medication?
Correct answer
D
Rationale
The correct answer is D: Reduced bronchial inflammation. Montelukast is a leukotriene receptor antagonist commonly used to manage asthma by reducing inflammation in the airways. This medication works by blocking the action of leukotrienes, which are chemicals in the body that contribute to inflammation, bronchoconstriction, and mucus production in the airways. By reducing bronchial inflammation, montelukast helps in improving breathing and reducing asthma symptoms.
Explanation for why other choices are incorrect:
A: Neutralized gastric acid - This is not a therapeutic effect of montelukast. Montelukast is not used to treat gastric acid-related issues.
B: Improved peripheral vasodilation - Montelukast does not affect peripheral vasodilation. It is primarily used for respiratory conditions.
C: Increased WBC count - Montelukast does not have a direct effect on increasing white blood cell count. It is not used for this purpose.
Explanation for why other choices are incorrect:
A: Neutralized gastric acid - This is not a therapeutic effect of montelukast. Montelukast is not used to treat gastric acid-related issues.
B: Improved peripheral vasodilation - Montelukast does not affect peripheral vasodilation. It is primarily used for respiratory conditions.
C: Increased WBC count - Montelukast does not have a direct effect on increasing white blood cell count. It is not used for this purpose.